Elizabeth Fabre

Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial

Kazuhiko Nakagawa, Edward B. Garon, Takashi Seto et al. · The Lancet Oncology · 2019 · 613 citations · Full text

Medicine, Oncology, Pharmacology +12

Induction of resident memory T cells enhances the efficacy of cancer vaccine

Mevyn Nizard, Hélène Roussel, Mariana O. Diniz et al. · Nature Communications · 2017 · 296 citations · Full text

Medicine, Immunology, Oncology +17

Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study

Manuela Tiako Meyo, Anne Jouinot, Etienne Giroux‐Leprieur et al. · Cancers · 2020 · 112 citations · Full text

Medicine, Oncology, Pharmacology +17

Analysis of Spontaneous Tumor-Specific CD4 T-cell Immunity in Lung Cancer Using Promiscuous HLA-DR Telomerase-Derived Epitopes: Potential Synergistic Effect with Chemotherapy Response

Yann Godet, Elizabeth Fabre, Magalie Dosset et al. · Clinical Cancer Research · 2012 · 97 citations

Life Sciences, Immunology, Oncology +17

Base-Position Error Rate Analysis of Next-Generation Sequencing Applied to Circulating Tumor DNA in Non-Small Cell Lung Cancer: A Prospective Study

Nicolas Pécuchet, Eleonora Zonta, Audrey Didelot et al. · PLoS Medicine · 2016 · 97 citations · Full text

Medicine, Molecular Medicine, Oncology +17